Allstate Investment Management’s DexCom DXCM Stock Holding History

Allstate Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.91M	Buy	+16,863	New	+$1.85M	0.06%	200

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allstate Investment Management's DXCM Position: Q4 2022 in Review

Allstate Investment Management opened a new position in DexCom (DXCM) in Q4 2022: 16,863 shares worth $1.91M. The stake represents 0.06% of the portfolio and ranks #200 among its holdings.

919 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

Allstate Investment Management held 16,863 shares of DexCom worth $1.91M as of Q4 2022.
DexCom was a new Allstate Investment Management position in Q4 2022.
DexCom made up 0.06% of Allstate Investment Management's portfolio in Q4 2022, its #200 holding.
919 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.